Profile
Name
SPDR S&P Biotech ETFAssets under management
$7 billionExpense ratio
0.35%Asset class
EquityDomicile
USInception date
January 31, 2006Net asset value
99K USDWebsite
http://www.ssga.comLast ex-dividend date
March 24, 2025Next ex-dividend date
N/AName
Weight
2.76 %
2.62 %
2.58 %
2.49 %
2.48 %
2.48 %
2.46 %
2.44 %
2.44 %
2.41 %
2.34 %
2.30 %
2.26 %
2.23 %
2.21 %
2.15 %
2.11 %
2.03 %
1.94 %
1.67 %
1.63 %
1.63 %
1.58 %
1.47 %
1.40 %
1.26 %
1.24 %
1.21 %
1.18 %
1.15 %
Price
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Technical Indicators
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Dividend per share
Dividend yield
Name
Weight
2.76 %
2.62 %
2.58 %
2.49 %
2.48 %
2.48 %
2.46 %
2.44 %
2.44 %
2.41 %
2.34 %
2.30 %
2.26 %
2.23 %
2.21 %
2.15 %
2.11 %
2.03 %
1.94 %
1.67 %
1.63 %
1.63 %
1.58 %
1.47 %
1.40 %
1.26 %
1.24 %
1.21 %
1.18 %
1.15 %
Analyst ratings
FAQ
- Does XBI pay dividends?
- What stocks are in XBI?
- What is the current assets under management for XBI?
- What is XBI average volume?
- What is XBI expense ratio?
- What is XBI inception date?
Does XBI pay dividends?
Yes, the SPDR S&P Biotech ETF does pays dividends, with
the most recent payment being
$0.01
per share. The last ex-dividend date was on March 24, 2025, and the next ex-dividend date has not been announced yet
What stocks are in XBI?
As of today, SPDR S&P Biotech ETF inlcudes 130 holdings, with 124 of them being companies from 4 different countries and 1 sectors. The most weighted holdings are Alnylam Pharmaceuticals (2.76%), Insmed Incorporated (2.62%) and Neurocrine Biosciences (2.58%)
What is the current assets under management for XBI?
Assets under management of SPDR S&P Biotech ETF is $7B
What is XBI average volume?
Average volume of SPDR S&P Biotech ETF is $8M
What is XBI expense ratio?
Expense ratio of SPDR S&P Biotech ETF is 0.35%
What is XBI inception date?
Inception date of SPDR S&P Biotech ETF is January 31, 2006